A CRO Partnership Your Biotech Company Deserves
For uncommon customer service, flexibility, speed, quality and comprehensive support throughout the entire biotech drug development lifecycle – choose Worldwide.
The success statistics for emerging biopharmas and biotechs are daunting. Developing a new prescription medicine that gains marketing approval is estimated to cost drug makers $2.6 billion1, and the approval rate for drugs entering clinical development is less than 12 percent.
Given the time, expense and risk, your choice of a development partner can be the deciding factor in your speed to market, economies of scale and successful navigation of regulatory requirements.
Worldwide offers 30+ years of experience in delivering the scientific and operational expertise, flexibility, innovation, personal service, and executive support and engagement successful biotechs demand of their development partner.